Opportunistic infections among individuals with HIV-1/AIDS in the highly active antiretroviral therapy era at a Quaternary Level Care Teaching Hospital

被引:8
|
作者
Galisteu, Katia Jaira [1 ]
Cardoso, Luciana Ventura [1 ]
da Cruz Furini, Adriana Antonia [1 ,2 ]
Schiesari Junior, Arlindo [3 ]
Cesarino, Claudia Bernardi [1 ]
Franco, Celia [4 ]
de Souza Baptista, Andrea Regina [5 ]
Dantas Machado, Ricardo Luiz [6 ]
机构
[1] Fac Med Sao Jose Do Rio Preto, Ctr Invest Microrganismos, Sao Paulo, Brazil
[2] Ctr Univ Rio Preto, Sao Paulo, Brazil
[3] Fac Integradas Padre Albino, Sao Paulo, Brazil
[4] Hosp Base, Sao Paulo, Brazil
[5] Univ Fed Fluminense, Dept Microbiol & Parasitol, Rio De Janeiro, Brazil
[6] Inst Evandro Chagas, Secao Parasitol, Ananindeua, Para, Brazil
关键词
HBV; HCV; HIV; Opportunistic infections; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; B-VIRUS; MYCOBACTERIUM-TUBERCULOSIS; COINFECTION; HIV; BRAZIL;
D O I
10.1590/0037-8682-0299-2014
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Introduction: In this study, clinical-laboratory and epidemiological characteristics are described for a group of 700 individuals with HIV (human immunodeficiency virus)/AIDS (acquired immunodeficiency syndrome) in the ART (antiretroviral therapy) era at a teaching hospital that provides a quaternary level of care, with an emphasis on opportunistic infections (OIs), co-infections and immune profile. Methods: A retrospective cross-sectional study of AIDS cases was conducted from 1998 to 2008 by reviewing medical records from the Base Hospital/FUNFARME (Fundacao Faculdade Regional de Medicina), Sao Jose do Rio Preto, Sao Paulo, Brazil. Results: The individuals were 14 to 75 years of age, and 458 were males. Heterosexuals accounted for 31.1% of all patients. Eighty-three percent were on ART, and 33.8% of those presented difficulties with treatment adherence. OIs were analyzed from medical records, and Pneumocystis jiroveci pneumonia was the most prevalent, regardless of the LTCD4(+) (TCD4(+) Lymphocytes) levels. Individuals whose viral loads were >= 10,000 showed a 90% greater chance of neurotoxoplasmosis. For P. jiroveci pneumonia, neurotoxoplasmosis, esophageal candidiasis, pulmonary tuberculosis and neurocryptococcosis, the chances of infection were higher among patients with LTCD4(+) levels below 200 cells/mm(3). HIV/hepatitis C virus (HCV) and HIV/hepatitis B virus (HBV) co-infections were significantly associated with death. Conclusions: OIs remain frequent in the ART era even in populations where the access to medical care is considered satisfactory.
引用
收藏
页码:149 / 156
页数:8
相关论文
共 50 条
  • [31] In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection?
    Perbost, I
    Malafronte, B
    Pradier, C
    Santo, LDI
    Dunais, B
    Counillon, E
    Vinti, H
    Enel, P
    Fuzibet, JG
    Cassuto, JP
    Dellamonica, P
    HIV MEDICINE, 2005, 6 (04) : 232 - 239
  • [32] Deletions in env gene of HIV-1 in AIDS patients treated with Highly Active Antiretroviral Therapy (HAART)
    Saurya, S
    Lichtenstein, Z
    Karpas, A
    JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (02) : 167 - 172
  • [33] Phenotypic T cell changes in HIV-1 infected individuals receiving highly active antiretroviral therapy
    Sullivan, AK
    Pires, A
    Hardy, GAD
    Gotch, FM
    Gazzard, BG
    Imami, N
    AIDS, 2000, 14 : S75 - S75
  • [34] European HIV/AIDS case reporting: assessing past treatment history in individuals who develop AIDS in the era of highly active antiretroviral therapy
    Semaille, CH
    Downs, AM
    Hamers, FF
    AIDS, 2003, 17 (02) : 270 - 272
  • [35] Adherence to highly active antiretroviral therapy in depressed patients with HIV/AIDS attending a Nigerian university teaching hospital clinic
    Olisah, V. O.
    Baiyewu, O.
    Sheikh, T. L.
    AFRICAN JOURNAL OF PSYCHIATRY, 2010, 13 (04) : 275 - 279
  • [36] Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy
    Gillini, LA
    Cingolani, A
    Murri, R
    De Luca, A
    Di Giambenedetto, S
    Wu, A
    Cauda, R
    Chaisson, RE
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (05) : 546 - 547
  • [37] Arresting HIV-1 evolution with highly active antiretroviral therapy (HAART)
    Persaud, D
    Hermankova, M
    Ruff, C
    Ray, SC
    Siliciano, RF
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1221 - 1221
  • [38] Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era
    Bedimo R.
    Current HIV/AIDS Reports, 2008, 5 (3) : 140 - 149
  • [39] Efficacy of highly active antiretroviral therapy in HIV-1 infected children
    van Rossum, AMC
    Fraaij, PLA
    de Groot, R
    LANCET INFECTIOUS DISEASES, 2002, 2 (02): : 93 - 102
  • [40] Potential for the transmission of HIV-1 despite highly active antiretroviral therapy
    Haase, AT
    Schacker, TW
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (25): : 1846 - 1848